There are two mechanisms of PD-L1 expression on tumor cells: 1) through genetic alterations or activation of certain signaling pathways (intrinsic immune resistance), 2) through an induced response to inflammatory signals (adaptive immune resistance) [8–10]. This evidence concerns the gene CD274 and neoplasm.